Vernon Hills, IL, United States of America

Artour Gomtsian


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):

Certainly! Here is the article about inventor Artour Gomtsian:

Title: Unveiling the Innovations of Artour Gomtsian in the Realm of Antiviral Compounds

Introduction:

Artour Gomtsian is a visionary inventor based in Vernon Hills, IL (US), who has made significant contributions to the field of antiviral compounds. With a keen focus on inhibiting RSV infection and replication, his inventive spirit has led to the development of groundbreaking solutions in the pharmaceutical industry.

Latest Patents:

Gomtsian's latest patents showcase his ingenuity in developing antiviral compounds:

1. Thiazoles and uses thereof - A patent revolving around compounds that inhibit RSV infection and replication, along with methods of preparation, compositions, and usage.

2. Substituted cyanoguanidines as oral anti-virals - Another patent highlighting compounds that inhibit RSV infection and replication, accompanied by related aspects like methods of preparation, compositions, and usage.

Career Highlights:

Artour Gomtsian is an invaluable asset to AbbVie Inc., where his innovative ideas have flourished. With two patents under his belt, his expertise and dedication have propelled the company towards new frontiers in antiviral research and development.

Collaborations:

Gomtsian's collaborative efforts with colleagues such as Iok Chan Ng and M-akhteruzzaman Molla have paved the way for synergistic innovations. Together, they have worked tirelessly to advance the field of antiviral compounds and make meaningful contributions to healthcare.

Conclusion:

In conclusion, Artour Gomtsian's inventive prowess and commitment to excellence are evident in his groundbreaking patents and collaborative endeavors. His innovative mindset continues to inspire progress in the pharmaceutical industry, offering hope for improved antiviral treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…